ReportsWeb- Partnerships Licensing Investments and M&A Deals a

Partnerships Licensing Investments and M&A Deals and Trends for
April 2017 in Pharmaceuticals
ReportsWeb.com published “Licensing Investments and M&A Deals Market” from its
database. The report covers the market landscape and its growth prospects over the coming
years. The report also includes a discussion of the key vendors operating in this market.
Publisher's "Partnerships, Licensing, Investments and M&A Deals and Trends for April 2017 in
Pharmaceuticals" report is an essential source of data and trend analysis on partnerships,
licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The
report provides detailed information on partnership and licensing transactions, M&As,
equity/debt offerings, private equity, and venture financing registered in the pharmaceuticals
industry in April 2017. The report portrays detailed comparative data on the number of deals
and their value in the last six months, subdivided by deal types, various therapy areas, and
geographies. Additionally, the report provides information on the top financial advisory firms in
the pharmaceuticals industry.
Data presented in this report is derived from Publisher's proprietary in-house Pharmaceuticals
eTrack deals database and primary and secondary research.
For more information about this report: http://www.reportsweb.com/partnerships-licensing-
investments-and-manda-deals-and-trends-for-april-2017-in-pharmaceuticals
Scope
- Analysis of the market trends for the pharmaceutical industry in the global arena.
- Review of deal trends in the cardiovascular, central nervous system, dermatology, ear nose
throat disorders, gastrointestinal, genito urinary system and sex hormones, hematological
disorders, hormonal disorders, immunology, infectious disease, male health, metabolic
disorders, mouth and dental disorders, musculoskeletal, oncology, ophthalmology, respiratory,
toxicology, and women's health segments.
- Analysis of partnerships, licensing, M&As, equity/debt offerings, private equity, and venture
financing deals in the pharmaceutical industry.
- Analysis of therapy areas which are very active in terms of venture capital financing,
partnerships, licensing agreements, equity/debt offerings, and M&As.
- Analysis of deals based on different payment modes, including upfront and milestone